Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 17  •  04:00PM ET
70.06
Dollar change
+0.68
Percentage change
0.98
%
Index
S&P 500
P/E
34.67
EPS (ttm)
2.02
Insider Own
0.67%
Shs Outstand
195.10M
Perf Week
-1.61%
Market Cap
13.67B
Forward P/E
13.92
EPS next Y
5.03
Insider Trans
1.24%
Shs Float
193.81M
Perf Month
-1.56%
Enterprise Value
16.04B
PEG
1.42
EPS next Q
1.10
Inst Own
104.49%
Perf Quarter
-14.88%
Income
401.40M
P/S
3.29
EPS this Y
12.05%
Inst Trans
-0.83%
Perf Half Y
1.89%
Sales
4.15B
P/B
1.63
EPS next Y
9.03%
ROA
3.26%
Perf YTD
-14.52%
Book/sh
42.87
P/C
109.36
EPS next 5Y
9.81%
ROE
4.87%
52W High
89.83 -22.01%
Perf Year
-11.89%
Cash/sh
0.64
P/FCF
27.83
EPS past 3/5Y
-1.15% 9.30%
ROIC
3.92%
52W Low
61.78 13.41%
Perf 3Y
-24.56%
EV/EBITDA
14.64
Sales past 3/5Y
7.35% 10.98%
Gross Margin
60.69%
Volatility
2.44% 2.39%
Perf 5Y
-29.86%
EV/Sales
3.86
EPS Y/Y TTM
-2.65%
Oper. Margin
17.19%
ATR (14)
1.86
Perf 10Y
79.38%
Quick Ratio
0.79
Sales Y/Y TTM
5.69%
Profit Margin
9.67%
RSI (14)
40.29
Current Ratio
1.34
EPS Q/Q
28.28%
SMA20
-0.85%
Beta
1.00
Debt/Eq
0.30
Sales Q/Q
6.16%
SMA50
-7.66%
Rel Volume
1.35
Prev Close
69.38
Employees
15000
LT Debt/Eq
0.22
SMA200
-6.12%
Avg Volume
1.96M
Price
70.06
IPO
Jan 21, 1983
Option/Short
Yes / Yes
Trades
Volume
2,654,097
Change
0.98%
Date Action Analyst Rating Change Price Target Change
Mar-04-26Downgrade Rothschild & Co Redburn Buy → Neutral $85
Feb-03-26Reiterated Needham Buy $100 → $99
Nov-13-25Downgrade Wells Fargo Overweight → Equal Weight $72
Oct-13-25Initiated Barclays Overweight $85
Oct-01-25Initiated Goldman Sell $64
Aug-28-25Downgrade Citigroup Buy → Neutral $72
Jul-22-25Upgrade BNP Paribas Exane Neutral → Outperform $92
Jun-17-25Upgrade Needham Hold → Buy $94
May-30-25Downgrade JP Morgan Overweight → Neutral $76
Aug-29-24Reiterated Piper Sandler Overweight $115 → $120
Apr-09-26 08:05AM
Mar-17-26 08:19AM
Mar-13-26 11:55AM
Mar-09-26 05:24PM
09:40AM
09:15AM Loading…
09:15AM
Mar-07-26 08:15AM
Mar-06-26 04:42PM
12:45PM
11:18AM
10:45AM
10:05AM
09:45AM
09:20AM
09:14AM
08:30AM Loading…
08:30AM
06:29AM
03:05AM
12:01AM
Mar-05-26 08:18PM
06:00PM
05:30PM
04:33PM
04:15PM
Mar-04-26 09:39AM
07:59AM
07:54AM
Mar-03-26 05:15PM
Mar-02-26 09:36AM
09:15AM
10:00AM Loading…
Feb-26-26 10:00AM
Feb-25-26 08:28AM
Feb-24-26 07:30PM
12:31PM
08:31AM
Feb-23-26 08:46AM
08:45AM
Feb-18-26 07:42AM
Feb-17-26 01:44PM
09:27AM
Feb-13-26 11:40AM
Feb-11-26 01:34PM
Feb-10-26 09:23AM
Feb-05-26 04:15PM
Feb-04-26 05:20PM
Feb-03-26 01:17PM
12:10PM
08:05AM
Feb-02-26 11:57AM
Jan-29-26 11:38PM
12:17PM
Jan-28-26 11:40AM
Jan-27-26 12:19PM
09:45AM
Jan-26-26 09:40AM
Jan-23-26 01:50PM
07:57AM
Jan-22-26 11:08AM
10:43AM
Jan-21-26 11:43AM
Jan-14-26 12:50PM
Jan-13-26 11:16AM
Jan-12-26 11:40AM
Jan-07-26 03:00PM
Jan-06-26 08:00AM
Jan-05-26 07:17AM
Jan-01-26 10:32PM
Dec-31-25 07:36AM
Dec-30-25 02:04PM
07:33AM
Dec-29-25 04:15PM
Dec-26-25 11:40AM
Dec-23-25 08:00AM
Dec-22-25 12:12PM
Dec-19-25 09:55AM
Dec-16-25 11:05PM
11:37AM
Dec-12-25 09:50AM
Dec-11-25 07:34AM
12:31AM
Dec-10-25 11:40AM
Dec-08-25 09:40AM
09:15AM
Dec-05-25 11:11AM
11:02AM
09:11AM
07:36AM
02:46AM
12:31AM
12:02AM
Dec-04-25 06:30PM
05:25PM
04:45PM
04:20PM
04:15PM
Dec-03-25 05:15PM
12:45PM
Dec-02-25 10:04PM
Dec-01-25 09:15AM
06:11AM
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WEISS ROBERT SDirectorApr 01 '26Option Exercise0.003,6540292,599Apr 06 05:16 PM
Rivas MariaDirectorApr 01 '26Option Exercise0.003,32203,322Apr 06 05:16 PM
Jay ColleenDirectorApr 01 '26Option Exercise0.003,322039,907Apr 06 05:16 PM
Carbone BarbaraDirectorApr 01 '26Option Exercise0.003,05003,050Apr 06 05:15 PM
MADDEN TERESA SDirectorApr 01 '26Option Exercise0.003,322015,679Apr 06 05:15 PM
Lucchese Cynthia LDirectorApr 01 '26Option Exercise0.003,322012,767Apr 06 05:14 PM
Kurzius Lawrence ErikDirectorApr 01 '26Option Exercise0.003,322011,099Apr 06 05:14 PM
Jay ColleenDirectorJan 12 '26Option Exercise39.407,064278,32236,585Jan 14 04:05 PM
White Albert G IIIPresident & CEOJan 08 '26Option Exercise0.0018,3400254,491Jan 12 04:24 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Jan 08 '26Option Exercise0.0011,518029,837Jan 12 04:24 PM
Sheffield Holly RPresident, CSIJan 08 '26Option Exercise0.008,050047,102Jan 12 04:23 PM
McBride Daniel GEVP & Chief Operating OfficerJan 08 '26Option Exercise0.0012,887076,007Jan 12 04:23 PM
Andrews Brian GEVP, CFO & TreasurerJan 08 '26Option Exercise0.003,528010,430Jan 12 04:22 PM
Lucchese Cynthia LDirectorDec 22 '25Buy84.061,784149,9639,445Dec 23 04:08 PM
Rivas MariaDirectorDec 18 '25Buy82.131,00082,13011,141Dec 19 04:18 PM
Kurzius Lawrence ErikDirectorDec 17 '25Buy82.502,000165,0007,777Dec 17 05:06 PM
Sheffield Holly RPresident, CSIDec 16 '25Buy80.751,23099,32239,052Dec 16 06:36 PM
White Albert G IIIPresident & CEODec 16 '25Buy80.8010,000808,000236,151Dec 16 06:36 PM
Kurzius Lawrence ErikDirectorSep 29 '25Buy68.392,000136,7805,777Sep 29 08:36 PM
White Albert G IIIPresident & CEOSep 05 '25Buy68.3910,000683,900226,151Sep 05 05:10 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Sep 05 '25Buy69.231,450100,38418,319Sep 05 04:07 PM
McBride Daniel GEVP & Chief Operating OfficerSep 02 '25Buy65.043,000195,12063,120Sep 02 05:17 PM
Andrews Brian GEVP, CFO & TreasurerSep 02 '25Buy65.681,525100,16222,191Sep 02 05:16 PM
Last Close
Apr 17  •  04:00PM ET
25.08
Dollar change
+0.46
Percentage change
1.87
%
STAA Staar Surgical Co daily Stock Chart
Index
RUT
P/E
-
EPS (ttm)
-1.63
Insider Own
0.69%
Shs Outstand
49.40M
Perf Week
-5.14%
Market Cap
1.24B
Forward P/E
39.79
EPS next Y
0.63
Insider Trans
-
Shs Float
49.17M
Perf Month
34.98%
Enterprise Value
1.09B
PEG
-
EPS next Q
0.03
Inst Own
109.54%
Perf Quarter
19.60%
Income
-80.45M
P/S
5.19
EPS this Y
138.88%
Inst Trans
-1.93%
Perf Half Y
-2.79%
Sales
239.44M
P/B
3.60
EPS next Y
62.09%
ROA
-16.57%
Perf YTD
8.62%
Book/sh
6.97
P/C
6.62
EPS next 5Y
-
ROE
-21.70%
52W High
30.81 -18.60%
Perf Year
48.49%
Cash/sh
3.79
P/FCF
-
EPS past 3/5Y
- -
ROIC
-21.36%
52W Low
15.59 60.92%
Perf 3Y
-62.99%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-5.57% 7.93%
Gross Margin
74.01%
Volatility
5.27% 5.68%
Perf 5Y
-78.78%
Dividend TTM
-
EV/Sales
4.56
EPS Y/Y TTM
-296.85%
Oper. Margin
-20.26%
ATR (14)
1.33
Perf 10Y
222.37%
Dividend Ex-Date
-
Quick Ratio
3.74
Sales Y/Y TTM
-23.72%
Profit Margin
-33.60%
RSI (14)
67.06
Dividend Gr. 3/5Y
- -
Current Ratio
4.55
EPS Q/Q
47.04%
SMA20
17.31%
Beta
1.10
Payout
-
Debt/Eq
0.11
Sales Q/Q
18.08%
SMA50
29.13%
Rel Volume
0.64
Prev Close
24.62
Employees
957
LT Debt/Eq
0.09
SMA200
8.98%
Avg Volume
1.40M
Price
25.08
IPO
Jul 07, 1983
Option/Short
Yes / Yes
Trades
Volume
894,231
Change
1.87%
Date Action Analyst Rating Change Price Target Change
Apr-09-26Upgrade Canaccord Genuity Hold → Buy $27
Feb-03-26Initiated Wedbush Neutral $26
Jan-16-26Resumed Morgan Stanley Underweight $13
Apr-21-25Initiated Wells Fargo Equal Weight $17
Feb-12-25Downgrade William Blair Outperform → Mkt Perform
Feb-12-25Downgrade Mizuho Outperform → Neutral $45 → $17
Feb-12-25Downgrade Jefferies Buy → Hold
Feb-12-25Downgrade BTIG Research Buy → Neutral
Jul-15-24Downgrade Morgan Stanley Equal-Weight → Underweight $50 → $37
Jun-11-24Upgrade BTIG Research Neutral → Buy $46
Apr-09-26 01:32PM
06:26AM
Apr-08-26 04:01PM
Mar-17-26 06:57AM
Mar-04-26 08:30AM
12:02AM Loading…
12:02AM
Mar-03-26 07:02PM
05:15PM
04:34PM
04:21PM
04:02PM
04:01PM
Mar-02-26 09:36AM
Feb-26-26 05:30PM
Feb-25-26 04:01PM
12:31PM Loading…
Feb-24-26 12:31PM
08:31AM
Feb-23-26 04:01PM
08:46AM
08:45AM
Feb-19-26 12:08PM
Feb-18-26 05:18AM
Feb-17-26 04:01PM
Feb-09-26 11:37PM
Feb-05-26 10:00AM
07:55AM
Feb-04-26 01:27PM
Feb-03-26 10:00AM
09:34AM
05:23AM
12:55PM Loading…
Feb-02-26 12:55PM
07:00AM
Jan-30-26 01:00PM
Jan-25-26 08:18PM
Jan-23-26 04:35PM
Jan-16-26 08:39PM
09:32AM
08:02AM
05:00AM
Jan-15-26 11:04PM
01:06PM
08:30AM
Jan-13-26 08:45AM
Jan-07-26 07:38AM
Jan-06-26 08:00PM
12:32PM
12:14PM
09:52AM
08:47AM
06:13AM
Dec-19-25 03:51PM
12:59PM
11:45AM
Dec-17-25 06:47PM
04:53PM
01:17PM
10:55AM
Dec-16-25 03:58PM
01:32PM
09:12AM
07:00AM
Dec-15-25 06:35PM
Dec-12-25 05:29PM
08:40AM
Dec-11-25 08:06PM
11:41AM
09:47AM
07:00AM
Dec-10-25 01:34PM
07:05AM
Dec-09-25 02:25PM
02:16PM
12:39PM
12:00PM
08:30AM
Dec-08-25 04:11PM
01:28PM
08:16AM
08:00AM
Dec-04-25 10:35PM
Dec-03-25 12:02PM
Dec-02-25 04:14PM
Nov-26-25 03:34PM
Nov-18-25 04:15PM
Nov-12-25 02:35PM
Nov-10-25 06:38PM
01:00PM
08:00AM
Nov-07-25 04:22PM
10:10AM
Nov-06-25 06:21AM
Nov-05-25 04:27PM
04:01PM
Nov-04-25 11:32PM
03:13PM
11:52AM
01:00AM
Oct-31-25 12:00PM
11:14AM
Oct-27-25 04:43PM
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Foust WarrenInterim Co-CEO and Pres. & COOMar 14 '26Option Exercise0.0029,325063,588Mar 16 05:00 PM
Foust WarrenInterim Co-CEO and Pres. & COOMar 12 '26Option Exercise0.008,175034,263Mar 16 05:00 PM
Michna MagdaChief Development OfficerMar 14 '26Option Exercise0.0017,595036,001Mar 16 05:00 PM
Michna MagdaChief Development OfficerMar 12 '26Option Exercise0.006,178020,622Mar 16 05:00 PM
BROADWOOD PARTNERS, L.P.DirectorMar 13 '26Buy18.61316,0175,882,65616,123,842Mar 13 07:59 PM
BROADWOOD PARTNERS, L.P.DirectorMar 12 '26Buy18.12299,4325,424,33015,807,825Mar 13 07:59 PM
BROADWOOD PARTNERS, L.P.DirectorMar 11 '26Buy17.5254,764959,55815,508,393Mar 13 07:59 PM
Jiang WeiDirectorJan 12 '26Option Exercise0.0020,967066,444Jan 14 05:48 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 09 '26Buy22.0527,485606,13815,453,629Jan 13 09:30 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 06 '26Buy21.62336,9467,284,28115,356,437Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 07 '26Buy22.0066,4671,462,30115,422,904Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 08 '26Buy21.943,24071,08215,426,144Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 21 '25Buy27.86797,48622,218,83715,019,491Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 20 '25Buy27.14393,38210,675,32514,222,005Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 19 '25Buy26.42309,1328,166,15513,828,623Nov 21 09:55 PM
Jiang WeiDirectorNov 12 '25Option Exercise0.0020,967045,477Nov 14 06:00 PM
Jiang WeiDirectorAug 12 '25Option Exercise0.0020,967024,510Aug 13 06:39 PM
WEISNER AIMEE SFormer DirectorAug 05 '25Proposed Sale26.871,75047,025Aug 05 06:38 PM
WEISNER AIMEE SFormer DirectorAug 05 '25Proposed Sale26.8713,491362,523Aug 05 06:33 PM
Last Close
Apr 17  •  04:00PM ET
25.68
Dollar change
+0.81
Percentage change
3.26
%
EYE National Vision Holdings Inc daily Stock Chart
Index
RUT
P/E
69.41
EPS (ttm)
0.37
Insider Own
2.19%
Shs Outstand
79.42M
Perf Week
0.04%
Market Cap
2.04B
Forward P/E
20.49
EPS next Y
1.25
Insider Trans
-2.61%
Shs Float
77.69M
Perf Month
-8.22%
Enterprise Value
2.70B
PEG
0.83
EPS next Q
0.43
Inst Own
117.49%
Perf Quarter
-12.74%
Income
29.60M
P/S
1.03
EPS this Y
23.75%
Inst Trans
3.56%
Perf Half Y
-5.41%
Sales
1.99B
P/B
2.35
EPS next Y
26.58%
ROA
1.38%
Perf YTD
-0.54%
Book/sh
10.95
P/C
52.70
EPS next 5Y
24.76%
ROE
3.51%
52W High
30.02 -14.46%
Perf Year
120.05%
Cash/sh
0.49
P/FCF
27.77
EPS past 3/5Y
-11.20% -3.46%
ROIC
2.03%
52W Low
10.75 138.88%
Perf 3Y
24.78%
Dividend Est.
-
EV/EBITDA
17.88
Sales past 3/5Y
-0.30% 3.03%
Gross Margin
54.18%
Volatility
4.12% 5.72%
Perf 5Y
-46.03%
Dividend TTM
-
EV/Sales
1.36
EPS Y/Y TTM
203.65%
Oper. Margin
3.00%
ATR (14)
1.47
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.33
Sales Y/Y TTM
5.55%
Profit Margin
1.49%
RSI (14)
49.00
Dividend Gr. 3/5Y
- -
Current Ratio
0.55
EPS Q/Q
111.18%
SMA20
0.14%
Beta
1.28
Payout
0.00%
Debt/Eq
0.80
Sales Q/Q
15.12%
SMA50
-3.91%
Rel Volume
1.21
Prev Close
24.87
Employees
13138
LT Debt/Eq
0.68
SMA200
-1.74%
Avg Volume
1.31M
Price
25.68
IPO
Oct 26, 2017
Option/Short
Yes / Yes
Trades
Volume
1,590,353
Change
3.26%
Date Action Analyst Rating Change Price Target Change
Dec-10-25Initiated Guggenheim Buy $32
Jul-30-25Initiated Roth Capital Buy $36
Jul-08-25Upgrade Barclays Equal Weight → Overweight $30
May-09-25Upgrade Citigroup Neutral → Buy $21
May-07-25Upgrade BofA Securities Underperform → Buy
Oct-17-23Downgrade Goldman Buy → Neutral $25 → $16
Jul-27-23Downgrade Wells Fargo Overweight → Equal Weight $30 → $21
Jul-27-23Downgrade Citigroup Buy → Neutral $28 → $22
May-02-23Downgrade Barclays Overweight → Equal Weight
Mar-31-23Upgrade Loop Capital Hold → Buy $23
Mar-24-26 09:40AM
Mar-23-26 07:00AM
Mar-17-26 07:00AM
Mar-12-26 04:00PM
07:00AM
09:05AM Loading…
Mar-10-26 09:05AM
08:00AM
Mar-05-26 09:40AM
07:43AM
Mar-04-26 04:02PM
03:17PM
12:32PM
10:36AM
09:30AM
07:10AM
06:27AM Loading…
06:27AM
06:17AM
06:12AM
06:00AM
Mar-02-26 10:01PM
Feb-26-26 09:55AM
Feb-25-26 09:40AM
Feb-24-26 08:00AM
Feb-23-26 11:41PM
11:40AM
Feb-20-26 09:50AM
Feb-19-26 10:37AM
Feb-18-26 07:00AM
Feb-16-26 11:39PM
Feb-10-26 11:43AM
11:11AM Loading…
11:11AM
Feb-06-26 09:31AM
Feb-05-26 09:25AM
Feb-04-26 12:15PM
09:34AM
Feb-01-26 11:43PM
Jan-30-26 08:05AM
Jan-29-26 08:48AM
Jan-28-26 09:55AM
09:50AM
Jan-27-26 06:25PM
Jan-26-26 12:10PM
Jan-25-26 11:34PM
Jan-22-26 09:49AM
09:40AM
Jan-16-26 07:50AM
Jan-15-26 03:46PM
02:36PM
Jan-13-26 07:00AM
Jan-11-26 11:31PM
Jan-07-26 06:07PM
11:46AM
Jan-06-26 04:05PM
Dec-30-25 11:31PM
Dec-19-25 09:09AM
Dec-18-25 11:32PM
11:30AM
Dec-16-25 10:36PM
Dec-10-25 11:03PM
Dec-05-25 11:30AM
Nov-26-25 08:00AM
Nov-18-25 02:15PM
Nov-17-25 06:45AM
Nov-12-25 12:32AM
Nov-06-25 06:00PM
09:30AM
12:31AM
Nov-05-25 12:25PM
07:20AM
06:25AM
06:16AM
06:00AM
Nov-03-25 10:23PM
Oct-31-25 07:10AM
Oct-28-25 12:01AM
Oct-22-25 08:00AM
Oct-09-25 11:31PM
Oct-07-25 09:01AM
Oct-01-25 12:39AM
Sep-30-25 12:32AM
Sep-25-25 09:31AM
Sep-19-25 05:09AM
Sep-02-25 04:40PM
Aug-20-25 08:00AM
Aug-19-25 09:00AM
Aug-13-25 01:35AM
Aug-12-25 08:22AM
03:06AM
Aug-08-25 03:43PM
Aug-07-25 01:00PM
Aug-06-25 07:10AM
06:19AM
06:09AM
06:00AM
Aug-05-25 09:44AM
08:00AM
Aug-04-25 11:02PM
Aug-01-25 11:13AM
Jul-30-25 09:40AM
08:21AM
National Vision Holdings, Inc. engages in the retail of optical products. It operates through the following segments: Owned and Host, Legacy, and Corporate and Other. The Owned and Host segment offers America's Best and Eyeglass World brands. The Legacy segment includes inventory and lab processing services. The Corporate and Other segment relates to the results of operations of the other operating segments and corporate overhead support. The company was founded in 1990 and is headquartered in Duluth, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wilkes AlexanderChief Executive OfficerMar 11 '26Sale26.5435,000928,90016,431Mar 12 04:15 PM
Wilkes AlexanderOfficerMar 11 '26Proposed Sale27.3035,000955,500Mar 11 10:59 AM
FAHS L READEExecutive ChairmanMar 06 '26Sale29.587,601224,838694,880Mar 09 04:19 PM
FAHS L READEExecutive ChairmanMar 06 '26Sale29.574,071120,379359,359Mar 09 04:19 PM
FAHS L READEMember of immediate family of Mar 06 '26Proposed Sale29.574,071120,391Mar 06 04:35 PM
FAHS L READEOfficerMar 06 '26Proposed Sale29.587,601224,862Mar 06 04:32 PM
Patel Priti VHead of Emerging BrandsMar 03 '26Option Exercise0.0011,951029,720Mar 04 04:24 PM
VanDette JosephChief Brand & Mktg OfficerMar 03 '26Option Exercise0.0025,394047,780Mar 04 04:24 PM
Clark BillSVP, Chief People OfficerMar 03 '26Option Exercise0.0025,394071,926Mar 04 04:23 PM
Brandman JaredChief Legal & Strategy OfficerMar 03 '26Option Exercise0.0025,394076,748Mar 04 04:23 PM
FAHS L READEExecutive ChairmanMar 03 '26Option Exercise0.00179,2480751,914Mar 04 04:22 PM
FAHS L READEExecutive ChairmanSep 16 '25Sale23.9310,598253,610532,195Sep 17 04:11 PM
FAHS L READEExecutive ChairmanSep 15 '25Sale23.812,00247,668542,793Sep 17 04:11 PM
FAHS L READEOfficerSep 16 '25Proposed Sale23.9310,598253,629Sep 16 04:16 PM
FAHS L READEOfficerSep 15 '25Proposed Sale23.812,00247,670Sep 15 04:12 PM
FAHS L READEExecutive ChairmanAug 28 '25Sale24.33137,4003,343,174544,795Aug 29 04:16 PM
FAHS L READEOfficerAug 28 '25Proposed Sale24.33137,4003,343,335Aug 28 04:16 PM
Molony MeganSVP, CHIEF MERCH. & MC OFFICERMay 15 '25Option Exercise15.0712,206183,94416,181May 16 04:30 PM
Molony MeganSVP, CHIEF MERCH. & MC OFFICERMay 14 '25Sale18.903,90073,7103,975May 16 04:30 PM
Moore Patrick R.Former OfficerMay 16 '25Proposed Sale19.1315,983305,751May 16 02:29 PM
Molony MeganOfficerMay 15 '25Proposed Sale18.6010,581196,807May 15 01:11 PM
Acharya RaviSVP, Chief Technology OfficerMay 13 '25Sale18.7512,000225,06011,700May 14 04:37 PM
Molony MeganOfficerMay 14 '25Proposed Sale18.903,90073,710May 14 11:53 AM
Acharya RaviOfficerMay 13 '25Proposed Sale18.7512,000225,060May 13 03:34 PM
Rasmussen MelissaFormer OfficerMay 07 '25Proposed Sale15.5128,869447,698May 07 05:03 PM